2019 Annual Meeting | C7 - Clinical Pearls in Autoimmune Neurology: Real World Cases

Date Saturday 05/04/19

Time 07:00 AM - 09:00 AM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Stacey Clardy, MD, PhD, FAAN

Topic(s) Autoimmune Neurology, Multiple Sclerosis

Learning Objectives Participants should be familiar with the spectrum of autoimmune and paraneoplastic neurological disorders, with a focus on the intersection of autoimmune neurology on all traditional neurology subspecialties, including movement disorders, epilepsy, behavioral/cognitive, neuromuscular, autonomic, demyelinating, and neurooncologic. Participants should also recognize the systemic manifestations associated with autoimmune neurologic disorders as clues to diagnosis, and be able to discriminate antibody-mediated neurologic disorders from mimics, including other autoinflammatory conditions, neurologic manifestations of rheumatologic disease, and immunodeficiency states with superimposed autoimmunity. There will be a focus on practical approaches to diagnosis treatment based on objective parameters and outcomes.

CME Available 2.00 CME credits

Core Competencies Medical Knowledge

Program Level Advanced

Program Tracks Advanced Practice Provider

Recommended Audience General Neurologist, Specialist Neurologist, Neurohospitalist

Teaching Styles Case-based, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:10 AM EDT	Introduction	Introduction and Overview: Approach to Suspected Autoimmune Neurologic Disease Stacey Clardy, MD, PhD, FAAN
07:10 AM - 08:50 AM EDT	Speaker	"Real World" Autoimmune Neurology Case Presentations Stacey Clardy, MD, PhD, FAAN, Maarten J. Titulaer, MD, PhD, Thais Armangue, MD
08:50 AM - 09:00 AM EDT	Speaker	Summary of Diagnosis and Management of Suspected Autoimmune Neurologic Conditions Stacey Clardy, MD, PhD, FAAN

Faculty Disclosures
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Maarten J. Titulaer, MD, PhD	The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received publishing royalties from a publication relating to health care.
Thais Armangue, MD	Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.

��ɫ��

��ɫ��